Abstract
To investigate the discrepancy between the apparent pharmacokinetic disposition of (+)-penicillamine in plasma and urine, the spontaneous degradation of (+)-penicillamine was studied in acidified and non-acidified urine. Degradation was prevented by acidification. The oxidized metabolites were converted to reduced (+)-penicillamine by electrolysis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergstrom R. F., Kay D. R., Wagner J. G. The in vitro loss of penicillamine in plasma, albumin solutions, and whole blood: implications for pharmacokinetic studies of penicillamine. Life Sci. 1980 Jul 21;27(3):189–198. doi: 10.1016/0024-3205(80)90137-x. [DOI] [PubMed] [Google Scholar]
- Butler M., Carruthers G., Harth M., Freeman D., Percy J., Rabenstein D. Pharmacokinetics of reduced D-penicillamine in patients with rheumatoid arthritis. Arthritis Rheum. 1982 Jan;25(1):111–116. doi: 10.1002/art.1780250120. [DOI] [PubMed] [Google Scholar]
- Saetre R., Rabenstein D. L. Determination of penicillamine in blood and urine by high performance liquid chromatography. Anal Chem. 1978 Feb;50(2):278–280. doi: 10.1021/ac50024a027. [DOI] [PubMed] [Google Scholar]